Nakamuraand Matsuzawa triglyceride degradation due to insulin resistance leads to an increase in remnant particles and a decrease in HDL.A recent study using LPL-overexpressed animals demonstrated that reducing hypertriglyceridemia, i.e. , decreasing remnant particles, markedly inhibited the progression of atherosclerosis (3). This meansthat active therapeutic intervention is desirable when dealing with conditions characterized by hypertriglyceridemia or high blood remnant particle levels, especially cases of syndromeXin whomdiabetes mellitus and insulin resistance are also seen. Hypertriglyceridemia is often accompanied by low blood HDLlevels. This is because HDLis formed as a result of degrading VLDLwhich includes triglyceride. Therefore, an increase in blood triglyceride promotes atherosclerosis by hampering the extravascular elimination of cholesterol accumulated within the vascular wall. In cases of hypertriglyceridemia, the production of remnant particles ( lipoprotein which is likely to accumulate in the vascular wall) and small dense LDLincreases, leading to accelerated vascular wall cholesterol accumulation and atherogenic changes in the blood vessel. Hyperlipidemia has important effects because, not only are vascular endothelial cells injured, they actually supply cholesterol which is then deposited in the vascular wall. Treatment of hyperlipidemia reduces the cholesterol level in plaques and normalizes the function of vascular endothelial cells, leading to plaque stabilization and inhibiting the onset of cardiovascular events.
Insulin resistance and pathophysiology Insulin resistance synergistically augments the potency of individual risk factors and thus accelerates atherosclerosis. The Japanese population is characterized by a low prevalence of obesity. Even in such a population, the metabolic abnormalities constituting syndrome X are recognizable. It is expected that improvement of insulin resistance and glucose tolerance will inhibit the onset of atherosclerosis by stabilizing plaques. It is nowdesirable to clarify howinsulin acts on the vascular wall and howinsulin resistance is involved in atherosclerosis, plaque formation, and cardiovascular events. Recently, the number of obese people has rapidly increased due to the changes in life-style in Japan. Obesity is defined as the over-accumulation of adipocytes, leading to various disorders such as hypertension, hyperlipidemia, glucose intolerance, and atherosclerotic vascular diseases. Several studies including ours have demonstrated that the excess accumulation of abdominal fat, especially intra-abdominal visceral fat easily leads to these disorders. Accordingly, we proposed the term 'visceral fat syndrome' defined as a highly atherogenic state associated with multiple risk factors based on visceral fat accumulation (1).
Weinvestigated 586 middle-aged menwhounderwent a health examination and computed tomographic scan for estimating abdominal fat distribution. One half of the subjects had excess visceral fat and frequently showed multiple risks and abnormalities on electrocardiogram both at rest and on exercise. The subjects with visceral fat accumulation had some lifestyle characteristics, which were unbalanced dietary habits, the lack of physical activity, and smoking habit. Wehave demonstrated several mechanisms by which visceral adipocytes maybe involved in the occurrence of life-style related disorders. The lipolytic substances such as free fatty acid (FFA) and glycerol derived from visceral fat adipocytes Life-style Related play an important role in the mechanisms. In the study using Otsuka Long Evans Tokushima fatty (OLETF) rats, an animal model for visceral fat accumulation, increased visceral fat brings about high portal FFAand the increased FFA induces the expressions of hepatic acyl-CoA synthetase (ACS), an important enzymefor triglyceride synthesis, and microsomal triglyceride transfer protein (MTP), a critical factor for very low-density lipoprotein (VLDL) synthesis and secretion, resulting in the increased VLDLlevels in plasma ( Fig. 1) (2) . Furthermore, aquaporin adipose (AQPap), which has recently been cloned by us, also mayplay a key role in a mechanism through glycerol metabolism (3). Glycerol released from adipocytes may be utilized as a substance for gluconeogenesis in liver. This membranemolecule is considered as a glycerol channel expressed in visceral adipose tissue and AQP9is considered as a glycerol channel specifically expressed in liver (4). In the study using obese diabetic db/db mice, portal glycerol and systemic glucose levels were significantly higher and both expressions of AQPapin visceral fat and AQP9in liver were significantly increased compared to those in control lean mice. These re-
Figure1. Molecular mechanism of hyperlipidemia and diabetes mellitus in visceral fat accumulation. suits suggest that the increased expressions of visceral fat AQPap and hepatic AQP9 may be involved in the development of diabetes mellitus through the increased glycerol release and uptake (Fig. 1) . Wealso analyzed the expressed genes in adipose tissue by large scale random sequencing. Unexpectedly, adipocytes, especially visceral adipocytes, expressed a variety of genes for secretory proteins including various bioactive substances; we designated them 'adipocytokines'. One of them, plasminogen activator inhibitor-1 (PAI-1 ) was overproduced in accumulated visceral fat and it might contribute to the development of vascular disease (5) . Wehave also cloned a novel adipose-specific gene namedadiponectin. Adiponectin is a collagen-like plasma protein and its plasma levels are paradoxically decreased in obesity especially in visceral obesity and diabetes mellitus with insulin resistance (6) . Adiponectin has been suggested to have potent antiatherogenicity, since this moleculewasshownto attenuate the TNF-oc-inducedexpression of adhesion molecules in vascular endothelial cells, and moreover, we found that the plasma adiponectin levels were significantly lower in patients with coronary artery disease than in age-and BMI-matched control subjects ( Fig. 2) (7) . Based on these results, it is thought that adipocytokines may play important and direct roles in the development of atherosclerosis by changing the plasma levels in the subjects with visceral fat syndrome. In summary, an over-accumulation of adipocytes, in particular, visceral adipocytes, causes the elevated portal FFAand glycerol to become hyperlipidemia or diabetes mellitus. Further, the elevated portal FFAbrings about the insulin resistance, and through this, hyperlipidemia and diabetes mellitus get worse, and hypertension occurs. Then the cluster of these lifestyle related disorders leads to vascular disease. Furthermore, adipocytokines originating from visceral fat such as PAI-1, adiponectin and so on, directly or indirectly transmit numerous effects on the development of vascular disease. Thus, it is very important for us to pay attention to visceral fat accumulation and to prevent the development of life-style related disease.
